- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NO Fingerprick: AI can detect low-glucose levels via ECG beats
![NO Fingerprick: AI can detect low-glucose levels via ECG beats NO Fingerprick: AI can detect low-glucose levels via ECG beats](https://medicaldialogues.in/h-upload/2020/01/21/750x450_123324-ecg-without-fingerprick-test.jpg)
"Our innovation consisted in using artificial intelligence for automatic detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping," said Dr Leandro Pecchia
Warwick: New technology for detecting low glucose levels via ECG using a non-invasive wearable sensor, which with the latest Artificial Intelligence can detect hypoglycaemic events from raw ECG signals has been made by researchers from the University of Warwick. Dr Leandro Pecchia with the new technology from the University of Warwick.
Currently, Continuous Glucose Monitors (CGM) are available by the NHS for hypoglycemia detection (sugar levels into blood or derma). They measure glucose in an interstitial fluid using an invasive sensor with a little needle, which sends alarms and data to a display device. In many cases, they require calibration twice a day with invasive finger-prick blood glucose level tests.
However, Dr. Leandro Pecchia's team at the University of Warwick have today, the 13th January 2020 published results in a paper titled 'Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG' in the Nature Springer journal Scientific Reports proving that using the latest findings of Artificial Intelligence (i.e., deep learning), they can detect hypoglycaemic events from raw ECG signals acquired with off-the-shelf non-invasive wearable sensors.
Two pilot studies with healthy volunteers found the average sensitivity and specificity of approximately 82% for hypoglycemia detection, which is comparable with the current CGM performance, although non-invasive.
Dr. Leandro Pecchia from the School of Engineering at the University of Warwick comments:
"Fingerpicks are never pleasant and in some circumstances are particularly cumbersome. Taking fingerpick during the night certainly is unpleasant, especially for patients in pediatric age.
"Our innovation consisted in using artificial intelligence for automatic detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping."
The figure shows the output of the algorithms over time: the green line represents normal glucose levels, while the red line represents the low glucose levels. The horizontal line represents the 4mmol/L glucose value, which is considered a significant threshold for hypoglycaemic events. The grey area surrounding the continuous line reflects the measurement error bar.
The Warwick model highlights how the ECG changes in each subject during a hypoglycaemic event. The figure below is an exemplar. The solid lines represent the average heartbeats for two different subjects when the glucose level is normal (green line) or low (red line). The red and green shadows represent the standard deviation of the heartbeats around the mean.
A comparison highlights that these two subjects have different ECG waveform changes during hypo events. In particular, Subject 1 presents a visibly longer QT interval during a hypo, while subject 2 does not.
The vertical bars represent the relative importance of each ECG wave in determining if a heartbeat is classified as hypo or normal.
From these bars, a trained clinician sees that for Subject 1, the T-wave displacement influences classification, reflecting that when the subject is in hypo, the repolarisation of the ventricles is slower.
In Subject 2, the most important components of the ECG are the P-wave and the rising of the T-wave, suggesting that when this subject is in hypo, the depolarization of the atria and the threshold for ventricular activation are particularly affected. This could influence subsequent clinical interventions.
This result is possible because the Warwick AI model is trained with each subject's own data. Intersubjective differences are so significant, that training the system using cohort data would not give the same results. Likewise, personalized therapy based on our system could be more effective than current approaches.
Dr Leandro Pecchia comments:
"The differences highlighted above could explain why previous studies using ECG to detect hypoglycaemic events failed. The performance of AI algorithms trained over cohort ECG-data would be hindered by these inter-subject differences."
"Our approach enables personalized tuning of detection algorithms and emphasizes how hypoglycaemic events affect ECG in individuals. Basing on this information, clinicians can adapt the therapy to each individual. Clearly more clinical research is required to confirm these results in wider populations. This is why we are looking for partners."
For more details click on the link: DOI: 10.1038/s41598-019-56927-5
Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email:Â editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751